Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study

Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study

Abstract Background BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Korea, demonstrated the efficacy and safety of nebivolol in Asian patients...

Full description

Bibliographic Details
Main Authors: Kyoung Im Cho, Dong Woon Jeon, Hyo Seung Ahn, Dong Kyu Jin, Hyun Sang Lee, Jong-Young Lee, Hong-Seok Lim, Athanasios J. Manolis, Seung-Woon Rha, Sang Won Park
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Clinical Hypertension
Subjects:
Essential hypertension
Nebivolol
Asian
Monotherapy
Combination therapy
Add-on therapy
Online Access:https://doi.org/10.1186/s40885-021-00165-3

Internet

https://doi.org/10.1186/s40885-021-00165-3

Similar Items